These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 28450929)

  • 1. Effect of intranasal stem cell administration on the nigrostriatal system in a mouse model of Parkinson's disease.
    Salama M; Sobh M; Emam M; Abdalla A; Sabry D; El-Gamal M; Lotfy A; El-Husseiny M; Sobh M; Shalash A; Mohamed WM
    Exp Ther Med; 2017 Mar; 13(3):976-982. PubMed ID: 28450929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intranasal administration of endometrial mesenchymal stem cells as a suitable approach for Parkinson's disease therapy.
    Bagheri-Mohammadi S; Alani B; Karimian M; Moradian-Tehrani R; Noureddini M
    Mol Biol Rep; 2019 Aug; 46(4):4293-4302. PubMed ID: 31123907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. bFGF promotes the differentiation and effectiveness of human bone marrow mesenchymal stem cells in a rotenone model for Parkinson's disease.
    Xiong N; Yang H; Liu L; Xiong J; Zhang Z; Zhang X; Jia M; Huang J; Zhang Z; Mohamed AA; Lin Z; Wang T
    Environ Toxicol Pharmacol; 2013 Sep; 36(2):411-422. PubMed ID: 23770451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicotine-Induced Neuroprotection in Rotenone In Vivo and In Vitro Models of Parkinson's Disease: Evidences for the Involvement of the Labile Iron Pool Level as the Underlying Mechanism.
    Mouhape C; Costa G; Ferreira M; Abin-Carriquiry JA; Dajas F; Prunell G
    Neurotox Res; 2019 Jan; 35(1):71-82. PubMed ID: 30006684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective A
    Fathalla AM; Soliman AM; Moustafa AA
    Neurosci Lett; 2017 Mar; 643():89-96. PubMed ID: 28213070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colchicine protects dopaminergic neurons in a rat model of Parkinson's disease.
    Salama M; Ellaithy A; Helmy B; El-Gamal M; Tantawy D; Mohamed M; Sheashaa H; Sobh M; Arias-Carrión O
    CNS Neurol Disord Drug Targets; 2012 Nov; 11(7):836-43. PubMed ID: 23198691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic low-dose melatonin treatment maintains nigrostriatal integrity in an intrastriatal rotenone model of Parkinson's disease.
    Carriere CH; Kang NH; Niles LP
    Brain Res; 2016 Feb; 1633():115-125. PubMed ID: 26740407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic Targeting of Human Olfactory Mucosa Stem Cells Following Intranasal Administration: a Novel Approach to Parkinson's Disease Treatment.
    Simorgh S; Bagher Z; Farhadi M; Kamrava SK; Boroujeni ME; Namjoo Z; Hour FQ; Moradi S; Alizadeh R
    Mol Neurobiol; 2021 Aug; 58(8):3835-3847. PubMed ID: 33860441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic effects of intranigral transplantation of mesenchymal stem cells in rat models of Parkinson's disease.
    Chen D; Fu W; Zhuang W; Lv C; Li F; Wang X
    J Neurosci Res; 2017 Mar; 95(3):907-917. PubMed ID: 27617772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Olfactory mucosa stem cells delivery via nasal route: a simple way for the treatment of Parkinson disease.
    Simorgh S; Alizadeh R; Shabani R; Karimzadeh F; Seidkhani E; Majidpoor J; Moradi F; Kasbiyan H
    Neurotox Res; 2021 Jun; 39(3):598-608. PubMed ID: 33433781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methodology and effects of repeated intranasal delivery of DNSP-11 in a rat model of Parkinson's disease.
    Stenslik MJ; Potts LF; Sonne JW; Cass WA; Turchan-Cholewo J; Pomerleau F; Huettl P; Ai Y; Gash DM; Gerhardt GA; Bradley LH
    J Neurosci Methods; 2015 Aug; 251():120-9. PubMed ID: 25999268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intranasal delivery of bone marrow-derived mesenchymal stem cells, macrophages, and microglia to the brain in mouse models of Alzheimer's and Parkinson's disease.
    Danielyan L; Beer-Hammer S; Stolzing A; Schäfer R; Siegel G; Fabian C; Kahle P; Biedermann T; Lourhmati A; Buadze M; Novakovic A; Proksch B; Gleiter CH; Frey WH; Schwab M
    Cell Transplant; 2014; 23 Suppl 1():S123-39. PubMed ID: 25302802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic effects of human mesenchymal and hematopoietic stem cells on rotenone-treated parkinsonian mice.
    Inden M; Takata K; Nishimura K; Kitamura Y; Ashihara E; Yoshimoto K; Ariga H; Honmou O; Shimohama S
    J Neurosci Res; 2013 Jan; 91(1):62-72. PubMed ID: 23073839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deciduous DPSCs Ameliorate MPTP-Mediated Neurotoxicity, Sensorimotor Coordination and Olfactory Function in Parkinsonian Mice.
    Simon C; Gan QF; Kathivaloo P; Mohamad NA; Dhamodharan J; Krishnan A; Sengodan B; Palanimuthu VR; Marimuthu K; Rajandas H; Ravichandran M; Parimannan S
    Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30699944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zinc (Zn) and adipose-derived mesenchymal stem cells (AD-MSCs) on MPTP-induced Parkinson's disease model: A comparative evaluation of behavioral and immunohistochemical results.
    Yildirim S; Oylumlu E; Ozkan A; Sinen O; Bulbul M; Goksu ET; Ertosun MG; Tanriover G
    Neurotoxicology; 2023 Jul; 97():1-11. PubMed ID: 37146888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of dopaminergic degeneration in a parkinsonian rat following micrografting of human bone marrow-derived neural progenitors.
    Glavaski-Joksimovic A; Virag T; Chang QA; West NC; Mangatu TA; McGrogan MP; Dugich-Djordjevic M; Bohn MC
    Cell Transplant; 2009; 18(7):801-14. PubMed ID: 19796495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of L-thyroxin in counteracting rotenone induced neurotoxicity in rats.
    Salama M; Helmy B; El-Gamal M; Reda A; Ellaithy A; Tantawy D; Mohamed M; El-Gamal A; Sheashaa H; Sobh M
    Environ Toxicol Pharmacol; 2013 Mar; 35(2):270-7. PubMed ID: 23357603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Aging in the Striatum and Substantia Nigra of a Parkinson's Disease Animal Model.
    Ureshino RP; Costa AJ; Erustes AG; Pereira GJDS; Sinigaglia-Coimbra R; Smaili SS
    Toxicol Pathol; 2018 Apr; 46(3):348-358. PubMed ID: 29683090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From Transcriptome to Behavior: Intranasal Injection of Late Passage Human Olfactory Stem Cells Displays Potential in a Rat Model of Parkinson's Disease.
    Alizadeh R; Boroujeni ME; Kamrava SK; Tehrani AM; Bagher Z; Heidari F; Bluyssen HAR; Farhadi M
    ACS Chem Neurosci; 2021 Jun; 12(12):2209-2217. PubMed ID: 34048212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polylysine-modified polyethylenimine (PEI-PLL) mediated VEGF gene delivery protects dopaminergic neurons in cell culture and in rat models of Parkinson's Disease (PD).
    Sheikh MA; Malik YS; Xing Z; Guo Z; Tian H; Zhu X; Chen X
    Acta Biomater; 2017 May; 54():58-68. PubMed ID: 28025049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.